Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Cervical Cancer

Free Subscription 05.10.2026 1 ACS Appl Mater Interfaces 1 Acta Biochim Biophys Sin (Shanghai) 1 Afr J Reprod Health 3 Asian Pac J Cancer Prev 1 Bioengineered 1 Biomedicines 2 Biomolecules 1 BMC Public Health 1 BMC Womens Health 1 BMJ Open Qual 1 Br J Gen Pract 2 Brachytherapy 1 Cancer Invest 1 Cancer Med 1 Cancer Prev Res (Phila) 2 Cancers (Basel) 1 Clin Cancer Res 1 Curr Issues Mol Biol 1 Curr Pharm Des 1 Dermatologie (Heidelb) 1 Diagn Microbiol Infect Dis 1 Diagnostics (Basel) 1 Drug Dev Ind Pharm 1 Eur J Nucl Med Mol Imaging 1 Eur J Radiol 1 Free Radic Biol Med 1 Front Cell Infect Microbiol 2 Front Immunol 4 Front Oncol 2 Front Public Health 1 Genet Test Mol Biomarkers 1 Glob Health Action 1 Gynecol Obstet Fertil Senol 1 Healthcare (Basel) 1 Histol Histopathol 1 Hum Vaccin Immunother 1 Infect Agent Cancer 2 Int J Gynaecol Obstet 1 Int J Infect Dis 1 Int J Mol Sci 1 J Appl Clin Med Phys 1 J Cancer Policy 1 J Gynecol Oncol 1 J Infect Public Health 1 J Med Radiat Sci 1 J Med Screen 1 J Nanobiotechnology 1 J Obstet Gynaecol Res 1 J Sex Med 2 J Surg Oncol 1 Lupus 1 Med J Malaysia 3 Medicine (Baltimore) 1 Mol Carcinog 1 Mol Ther 1 Mymensingh Med J 1 Nan Fang Yi Ke Da Xue Xue Bao 1 Neoplasia 1 Nurs Open 1 Oncol Rep 1 Pathogens 2 Pharmaceutics 1 PLoS One 1 Psychooncology 1 Public Health 1 Public Health Pract (Oxf) 1 Radiol Phys Technol 1 Res Sq 1 Virol J 1 Womens Health (Lond) 1 World J Radiol 3 Zhonghua Fu Chan Ke Za Zhi

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

ACS Appl Mater Interfaces

1. WANG J, Zhao J, Liu R, Qi X, et al
   Alkaline Phosphatase-Responsive Composite Hydrogels Modulating Tumor Mechanical Properties for Cervical Cancer Therapy.
   ACS Appl Mater Interfaces. 2026 Sep 30. doi: 10.1021/acsami.6c14164.
   PubMed         Abstract available
   
   

   
   Acta Biochim Biophys Sin (Shanghai)

2. JIN S, Gao D, Xiahou Y, Tao J, et al
   STC2 promotes cisplatin resistance through metabolic reprogramming and lactylation-mediated epigenetic regulation in cervical cancer.
   Acta Biochim Biophys Sin (Shanghai). 2026 Sep 29. doi: 10.3724/abbs.2026169.
   PubMed         Abstract available
   
   

   
   Afr J Reprod Health

3. TAOUAF J, Loukid M, Lamtali S
   Factors influencing compliance with cervical cancer screening guidelines among women aged 30 to 49 years in Morocco.
   Afr J Reprod Health. 2026;30.
   PubMed         Abstract available
   
   

   
   Asian Pac J Cancer Prev

4. SANTOS ABC, Carobeli LR, Meirelles LEF, De Souza MVF, et al
   Emerging Insights into Comparative Genetic Mutations in HPV-Associated and HPV-Independent Cervical Cancer: A Systematic Review.
   Asian Pac J Cancer Prev. 2026;27:3139-3150.
   PubMed         Abstract available
   
   
5. SERIKOVA-ESENGELDINA D, Issenova B, Siyazbekova Z, Samarova U, et al
   Global Trends and Disparities in Cervical Cancer Control in Central Asia (1990-2023): A Comparative Age-Period-Cohort and Joinpoint Regression Analysis.
   Asian Pac J Cancer Prev. 2026;27:3307-3313.
   PubMed         Abstract available
   
   
6. LIM MSH, Tan SSN, Bujang MA, Shandra JFA, et al
   A Cross-Sectional Study of Knowledge, Attitudes, and Perceptions toward HPV Vaccination Among Undergraduate Students Studying in Sarawak, Malaysia.
   Asian Pac J Cancer Prev. 2026;27:3365-3375.
   PubMed         Abstract available
   
   

   
   Bioengineered

7. 
   Statement of retraction: Transcriptional factor 3 binds to sirtuin 1 to activate the Wnt/beta-catenin signaling in cervical cancer.
   Bioengineered. 2026;17:2731276.
   PubMed        
   
   

   
   Biomedicines

8. XU T, Ma M, Zhang J, Wang Y, et al
   FABP4/5-Mediated Lipid Reprogramming Is Associated with Immunosuppressive T Cell Crosstalk in Cervical Cancer After Chemoradiotherapy.
   Biomedicines. 2026;14:2072.
   PubMed         Abstract available
   
   

   
   Biomolecules

9. LUO X, Li J, Xing T, Liu S, et al
   Low-Dose Paclitaxel Combined with Dehydrocavidine Synergistically Suppresses Cervical Cancer by Inhibiting FASN/SCD1-Mediated Lipid Metabolism.
   Biomolecules. 2026;16:1354.
   PubMed         Abstract available
   
   
10. AYAG ME, Tuncer MC, Ozturk S
    Epigallocatechin Gallate Modulates the Cellular Response to Doxorubicin in HeLa Cervical Cancer Cells.
    Biomolecules. 2026;16:1299.
    PubMed         Abstract available
    
    

    
    BMC Public Health

11. HEINERT SW, Salas R, Ohman-Strickland P, Ikechi R, et al
    Acceptability of HPV self-sampling in three urban academic emergency departments.
    BMC Public Health. 2026;26:2715.
    PubMed         Abstract available
    
    

    
    BMC Womens Health

12. ZHAO W, Sun Y, Ramadhany MMA, Wu R, et al
    Squamous cell carcinoma arising from ovarian mature cystic teratoma with concurrent cervical high-risk HPV infection and low-grade squamous intraepithelial lesion: a case report.
    BMC Womens Health. 2026;26:487.
    PubMed         Abstract available
    
    

    
    BMJ Open Qual

13. WANG M, Brand A, Plymoth M, Chen J, et al
    Implementation of self-collected cervical screening in an under-screened, culturally and linguistically diverse antenatal population: a quality improvement study.
    BMJ Open Qual. 2026;15:e004525.
    PubMed         Abstract available
    
    

    
    Br J Gen Pract

14. BURRELL A
    Yonder: Livestreaming clinical education, complaints, weather and mental health, and HPV and cervical cancer screening.
    Br J Gen Pract. 2026;76:463.
    PubMed        
    
    

    
    Brachytherapy

15. PRASARTSEREE T, Dankulchai P, Sittiwong W, Laolugsanalerd P, et al
    Hypofractionated 44 Gy in 20 fractions versus conventional chemoradiation in cervical cancer: 2-year results of the randomized HYPOCx-iRex trial with an exploratory pooled analysis of a single-institute EMBRACE-II cohort.
    Brachytherapy. 2026 Oct 1:S1538-4721(26)00306.
    PubMed         Abstract available
    
    
16. NARASIMHAN RM, Wassel M, Herbach E, McNeilly S, et al
    FEBE: The female brachytherapy experience. Assessing PTSD symptom rates in women treated for locally advanced cervical cancer with HDR brachytherapy.
    Brachytherapy. 2026 Sep 28:S1538-4721(26)00281.
    PubMed         Abstract available
    
    

    
    Cancer Invest

17. SHOARISHOAR SS, Seifollahi Marbini M
    Human Papillomavirus (HPV) and Cervical Cancer: An Exploratory Systematic Review of Heterogeneous Evidence on Epidemiology, Vaccination, Screening, and Molecular Advances.
    Cancer Invest. 2026 Sep 29:1-19. doi: 10.1080/07357907.2026.2740708.
    PubMed         Abstract available
    
    

    
    Cancer Med

18. LI Y, Li R, Duan R, Gu X, et al
    Assessment of Factors and Trends Affecting Different Pathological Types of Cervical Cancer in China From 2013 to 2022.
    Cancer Med. 2026;15:e72259.
    PubMed         Abstract available
    
    

    
    Cancer Prev Res (Phila)

19. KASZA KA, Schneller-Najm LM, Sheffer CE, Haring RC, et al
    Cancer Screening Adherence in the United States by Smoking and Vaping Status, 2023.
    Cancer Prev Res (Phila). 2026;19:587-599.
    PubMed         Abstract available
    
    

    
    Cancers (Basel)

20. TOTH R, Sebok P, Spanics C, Szerencses D, et al
    Beyond Access and Awareness: The Role of Patient Experience and Physician Communication in Cervical Cancer Screening Participation in Hungary.
    Cancers (Basel). 2026;18:2999.
    PubMed         Abstract available
    
    
21. KOURI MA, Kalkou ME, Platoni K, Kollaros N, et al
    Integrating Gold Nanoparticles with Brachytherapy: In Vitro Insights into Radiosensitization in Cervical Cancer.
    Cancers (Basel). 2026;18:3025.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

22. SRIDHAR S, Roukens MG, Yu CY, Dielen T, et al
    Molecular Profiling of Tisotumab Vedotin-Treated Patients Identifies Immune Pathways Associated with Clinical Activity.
    Clin Cancer Res. 2026;32:4365-4373.
    PubMed         Abstract available
    
    

    
    Curr Issues Mol Biol

23. YORDANOV A, Kostov S, Dimitrova PD, Hasan I, et al
    ROMO1 and CD47 in Cervical Cancer: Parallel but Independently Regulated.
    Curr Issues Mol Biol. 2026;48:862.
    PubMed         Abstract available
    
    

    
    Curr Pharm Des

24. NEDUNCHEZHIAN S, Palaniyandi T, Surendran H, Baskar G, et al
    Strategies for Cervical Cancer Treatment using the Regenerative Potentials of Mesenchymal Stem Cells.
    Curr Pharm Des. 2026 Sep 29. doi: 10.2174/0113816128501994260915105716.
    PubMed         Abstract available
    
    

    
    Dermatologie (Heidelb)

25. WIELAND U, Kreuter A
    [Vaccine prevention of HPV-associated diseases].
    Dermatologie (Heidelb). 2026;77:666-672.
    PubMed         Abstract available
    
    

    
    Diagn Microbiol Infect Dis

26. ANTORA HK, Mosaddeque MB, Mim NN, Tasnim J, et al
    Diagnostic utility of HPV-16/18 E6 mRNA fold change measured by in-house semi-quantitative real-time PCR in cervical cancer triage for differentiation of CIN3 and cervical cancer from lower-grade lesions.
    Diagn Microbiol Infect Dis. 2026;117:117668.
    PubMed         Abstract available
    
    

    
    Diagnostics (Basel)

27. SOZEN I, Turan Bakirci I, Ataseven E, Ustundag P, et al
    Routine Blood-Based Parameters Associated with Invasive Cervical Cancer Versus High-Grade Cervical Intraepithelial Neoplasia: Development of a Retrospective Diagnostic Prediction Model.
    Diagnostics (Basel). 2026;16:2884.
    PubMed         Abstract available
    
    

    
    Drug Dev Ind Pharm

28. TAWFEEK HM, A H Abddelatif A, Barakat H
    Spotlights on Cervical Cancer: Progression, Diagnosis and Clinical Manifestations, Epidemiology, Treatment Approaches, Role of Artificial Intelligence and Future Directions.
    Drug Dev Ind Pharm. 2026 Sep 28:1-28. doi: 10.1080/03639045.2026.2741083.
    PubMed         Abstract available
    
    

    
    Eur J Nucl Med Mol Imaging

29. WANG Y, Su Y, Zhang Y, Cai Y, et al
    Preoperative PET/CT phenotype of gastric-type endocervical adenocarcinoma: integrated morphological, metabolic, serological, and explainable machine-learning analysis.
    Eur J Nucl Med Mol Imaging. 2026;53:7204-7220.
    PubMed         Abstract available
    
    

    
    Eur J Radiol

30. KOU K, Yamanoi K, Kobara H, Komatsu H, et al
    Clinical significance of MRI-based tumor status differs by histological subtype in early-stage cervical cancer.
    Eur J Radiol. 2026;205:113271.
    PubMed         Abstract available
    
    

    
    Free Radic Biol Med

31. UEDA Y, Tsuji M, Mori M, Kusanagi A, et al
    Modulation of intracellular heme metabolism enhances artesunate-induced cytotoxicity in CD44v-positive cervical cancer cells.
    Free Radic Biol Med. 2026;257:66-76.
    PubMed         Abstract available
    
    

    
    Front Cell Infect Microbiol

32. LI H, Zhao H, Liang L, Chen M, et al
    Clinical significance of Chlamydia trachomatis and HPV coinfection across cervical lesion severity: a 10-year retrospective study in Southern China.
    Front Cell Infect Microbiol. 2026;16:1832343.
    PubMed         Abstract available
    
    

    
    Front Immunol

33. PAN YX, Chen WF, Li R, Zhang MJ, et al
    Prognostic impact of HLA-G expression in cervical squamous cell carcinoma: correlation with PD-L1 and CD8-positive tumor infiltrating lymphocytes.
    Front Immunol. 2026;17:1957106.
    PubMed         Abstract available
    
    
34. HUANG L, Wan Y, Yang Z, Zhou Z, et al
    HIV-associated immune remodeling in cervical cancer: implications for immunotherapy, biomarkers, and trial design.
    Front Immunol. 2026;17:1953030.
    PubMed         Abstract available
    
    

    
    Front Oncol

35. AN X, Jiao M, Dong ZW, Teng F, et al
    Ovarian dose prediction after ovarian transposition in cervical cancer: comparing three models and the impact of geometric distance on predictive performance.
    Front Oncol. 2026;16:1906826.
    PubMed         Abstract available
    
    
36. SRIRAM S
    Vaccinating girls, abandoning women: the financing asymmetry between HPV immunization and the cervical cancer treatment cascade in low- and middle-income countries.
    Front Oncol. 2026;16:1941545.
    PubMed         Abstract available
    
    
37. GU X, Xu M, Dai J, Li X, et al
    Case Report: PRaG 3.0 therapy for advanced cervical cancer with severe comorbidities.
    Front Oncol. 2026;16:1912098.
    PubMed         Abstract available
    
    
38. ALSHEHRI E, AlHakeem M, Almahmoud RA, AlKulyah AA, et al
    Cervical cancer prevention in Riyadh: a cross-sectional analysis of sociodemographic correlates, knowledge-awareness-practice gaps, and healthcare provider influence.
    Front Oncol. 2026;16:1890017.
    PubMed         Abstract available
    
    

    
    Front Public Health

39. LIU J, Liu Y, Jiang Y, Wang X, et al
    Declining trends but persistent disparities in cervical cancer mortality in the United States, 1999-2023.
    Front Public Health. 2026;14:1892243.
    PubMed         Abstract available
    
    
40. ZHAO Q, Yang C, Bu Q, Sun X, et al
    From HPV genotypes to cervical lesion burden: public health-relevant heterogeneity across 1.29 million screening records in Guangdong, China.
    Front Public Health. 2026;14:1897790.
    PubMed         Abstract available
    
    

    
    Genet Test Mol Biomarkers

41. SULTANA F, De A, Bose S, Roychowdhury A, et al
    Clinical Evaluation of miR-135b-5p and miR-21-5p Expression on Self-Collected Cervical Swab Samples for Triaging HR-HPV-Positive High-Grade Preneoplastic Lesions in India.
    Genet Test Mol Biomarkers. 2026;30:264-275.
    PubMed         Abstract available
    
    

    
    Glob Health Action

42. MACHANGE RF, Njau B, Mtuya CC, Katiti VW, et al
    Perspectives of women and healthcare providers on facilitators and barriers to cervical cancer screening in the rural Kilimanjaro region Tanzania: a qualitative study.
    Glob Health Action. 2026;19:2735552.
    PubMed         Abstract available
    
    

    
    Gynecol Obstet Fertil Senol

43. WILLEMART M, Bongrand C, Balaya V, Marcadet J, et al
    [Assessing and improving post-therapeutic surveillance of precancerous cervical lesions in Reunion Island].
    Gynecol Obstet Fertil Senol. 2026;54:475-479.
    PubMed         Abstract available
    
    

    
    Healthcare (Basel)

44. YORDANOV A, Yordanov T, Tsoneva E, Petrov I, et al
    Preventable, Yet Unprevented: The Cervical Cancer Screening Landscape in Eastern Europe and Bulgaria.
    Healthcare (Basel). 2026;14:2973.
    PubMed         Abstract available
    
    

    
    Histol Histopathol

45. QIAN C, Cai X, Shi L, Li A, et al
    Exosomal miR-143-3p released from cancer cells suppresses cervical cancer progression and promotes ferroptosis through directly targeting KLF5.
    Histol Histopathol. 2026 Oct 1:25146. doi: 10.14670.
    PubMed         Abstract available
    
    

    
    Hum Vaccin Immunother

46. ZHOU X, Yao D, Li T, Guo Z, et al
    Knowledge and attitudes of medical students about human papillomavirus (HPV) and HPV vaccine: A cross-sectional survey in Inner Mongolia, China.
    Hum Vaccin Immunother. 2026;22:2738975.
    PubMed         Abstract available
    
    

    
    Infect Agent Cancer

47. EFE CAMILI F, Aksu S
    HPV knowledge, awareness, and vaccine beliefs among women attending gynecological care in Turkiye: implications for cervical cancer prevention.
    Infect Agent Cancer. 2026;21:63.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

48. ZULFIKAROGLU E
    Barriers to pelvic examination and cervical cancer screening in women with sexual trauma histories and sexual pain disorders: A systematic review and clinical practice synthesis.
    Int J Gynaecol Obstet. 2026 Sep 26. doi: 10.1002/ijgo.71375.
    PubMed         Abstract available
    
    
49. PAREJA R, Heredia F, Sanchez-Diaz E, Cuello MA, et al
    FIGO/IGCS statement on the efficacy of topical treatments for high-risk human papillomavirus in preventing CIN 3+ lesions.
    Int J Gynaecol Obstet. 2026;175:18-25.
    PubMed         Abstract available
    
    

    
    Int J Infect Dis

50. DAI W, Liu Y, Du H, Guo C, et al
    Large-cohort screening projects in seven regions of China demonstrate the efficacy of extended HPV genotyping in triaging HPV-positive women.
    Int J Infect Dis. 2026;171:109077.
    PubMed         Abstract available
    
    

    
    Int J Mol Sci

51. YORDANOV A, Dimitrova VD
    Integrated Immune Escape in Cervical Cancer: HLA-I Dysfunction and Immune Checkpoint Signaling.
    Int J Mol Sci. 2026;27:8009.
    PubMed         Abstract available
    
    

    
    J Appl Clin Med Phys

52. JIANG H, Yuan Z, Liu Z, Wang Y, et al
    A hybrid deep learning framework for automated treatment planning in cervical cancer radiotherapy.
    J Appl Clin Med Phys. 2026;27:e70806.
    PubMed         Abstract available
    
    

    
    J Cancer Policy

53. DE PAEPE E, Bertucci S, Ssetaala A, Amenu D, et al
    Transitioning to HPV-based cervical cancer screening in four low- and middle-income countries: policy and implementation pathways from a scoping review.
    J Cancer Policy. 2026 Oct 1:100812. doi: 10.1016/j.jcpo.2026.100812.
    PubMed         Abstract available
    
    

    
    J Gynecol Oncol

54. ON S
    Comment of 'Subsequent primary cancer incidence in cervical cancer survivors: insights from a comprehensive cohort study utilizing combined Japanese population-based cancer registries'.
    J Gynecol Oncol. 2026 Sep 16. doi: 10.3802/jgo.2026.
    PubMed        
    
    

    
    J Infect Public Health

55. ALMESLAMANI AZ, Ahmad M, Nauman J, Ahmad LA, et al
    Human papillomavirus research in Gulf Cooperation Council (GCC) countries - current evidence, genotypes, and priority gaps: A scoping review.
    J Infect Public Health. 2026;19:103335.
    PubMed         Abstract available
    
    

    
    J Med Radiat Sci

56. AHMADI SH, Mohammadi SS, Koozari A, Elhaie M, et al
    Deep Learning and Machine Learning Algorithms for Cervical Cancer Segmentation on MRI: A Systematic Review.
    J Med Radiat Sci. 2026 Sep 27:10.1002/jmrs.70127. doi: 10.1002/jmrs.70127.
    PubMed         Abstract available
    
    

    
    J Med Screen

57. GILHAM C
    Socioeconomic inequalities in cervical cancer screening coverage in England.
    J Med Screen. 2026 Sep 30:9691413261484526. doi: 10.1177/09691413261484526.
    PubMed         Abstract available
    
    

    
    J Nanobiotechnology

58. FENG C, Wang J, Zhang Y, Feng Y, et al
    Tumor cell membrane?coated MOF?199 nanoparticles co?loaded with auranofin and celecoxib enhance single?dose radiotherapy and anti?PD?L1 therapy in cervical cancer.
    J Nanobiotechnology. 2026;24:916.
    PubMed         Abstract available
    
    

    
    J Obstet Gynaecol Res

59. MIYAKE T, Sasa H, Ito T, Watanabe T, et al
    Metastasis of Invasive Ductal Carcinoma of the Breast to the Uterine Cervix 30 Years Post-Mastectomy: A Case Report.
    J Obstet Gynaecol Res. 2026;52:e70509.
    PubMed         Abstract available
    
    

    
    J Sex Med

60. MECKLAI K, Mehta N, Oh C, Jabban S, et al
    Disparities in sexual health counseling and treatment among patients undergoing chemoradiation for the treatment of cervical cancer.
    J Sex Med. 2026;23:qdag304.
    PubMed        
    
    

    
    J Surg Oncol

61. XU Y, Du Y, Qin Z, Zheng A, et al
    Radical Hysterectomy for Non-Endometrioid Endometrial Cancer With Cervical Involvement: A Retrospective Cohort Study.
    J Surg Oncol. 2026;134:684-691.
    PubMed         Abstract available
    
    
62. PEACOCK AM, Brown KGM, Lee PJM, Austin KKS, et al
    Pelvic Exenteration for Cervical Cancer: Oncological, Morbidity and Quality of Life Outcomes.
    J Surg Oncol. 2026 Sep 30. doi: 10.1002/jso.70396.
    PubMed         Abstract available
    
    

    
    Lupus

63. JAVED M, Jagannath D, Mathew A, Harms K, et al
    Gaps in cervical cancer screening and HPV vaccination in women with systemic lupus erythematosus.
    Lupus. 2026 Oct 1:9612033261494026. doi: 10.1177/09612033261494026.
    PubMed        
    
    

    
    Med J Malaysia

64. YACOB SM, Malik RA
    Outcomes and patterns of management of metastatic/recurrent cervical carcinoma in Malaysia: A single institutional observational cohort study.
    Med J Malaysia. 2026;81:669-676.
    PubMed         Abstract available
    
    

    
    Medicine (Baltimore)

65. WU B, Liu Q
    Epidemiological characteristics of cervical cancer in Asian populations and risk factor inference based on Mendelian randomization.
    Medicine (Baltimore). 2026;105:e51015.
    PubMed         Abstract available
    
    
66. ALMALKI ZS, Alamer AA, Alhumaid SK, Alsuhibani AA, et al
    Cost-effectiveness of pembrolizumab plus chemoradiotherapy versus placebo plus chemoradiotherapy for high-risk locally advanced cervical cancer in Saudi Arabia: A model-based economic evaluation.
    Medicine (Baltimore). 2026;105:e50990.
    PubMed         Abstract available
    
    
67. KARIRI YA, Kuriry IA, Albargy HA, Keraryi FA, et al
    Sociodemographic correlates of human papilloma virus (HPV) and cervical cancer knowledge among Saudi women: A nationwide assessment.
    Medicine (Baltimore). 2026;105:e50955.
    PubMed         Abstract available
    
    

    
    Mol Carcinog

68. ZHANG L, Zhao F, Zhang L, Jia K, et al
    GNAS-AS1 Promotes M2-Like Macrophage Polarization, Contributing to Cervical Cancer Growth, Angiogenesis, and Metastasis Through the miR-518c-5p/FBXO38 Axis and MAPK Signaling.
    Mol Carcinog. 2026 Sep 27. doi: 10.1002/mc.70110.
    PubMed         Abstract available
    
    

    
    Mol Ther

69. KANG Y, Wu Y, Bao B, Wang X, et al
    Base editing-mediated induction of stop codons in HPV18 E6/E7 for cervical cancer therapy.
    Mol Ther. 2026 Sep 25:S1525-0016(26)00805-1. doi: 10.1016/j.ymthe.2026.
    PubMed         Abstract available
    
    

    
    Mymensingh Med J

70. SARKER RR, Ferdous J, Yeasmin S, Rahman S, et al
    Association between Serum Folate Status and Cervical Intraepithelial Neoplasia.
    Mymensingh Med J. 2026;35:1225-1233.
    PubMed         Abstract available
    
    

    
    Nan Fang Yi Ke Da Xue Xue Bao

71. MA Y, Liu Y, Gao N, Huo Y, et al
    [Multiple components in Astragalus Injection target CCL2/FOS/PPARG/CXCL8 to suppress cervical cancer progression].
    Nan Fang Yi Ke Da Xue Xue Bao. 2026;46:2206-2221.
    PubMed         Abstract available
    
    

    
    Neoplasia

72. LU W, Wang W, Sun L, Sun H, et al
    STAT5A-RNF8 signaling regulates homologous recombination repair and cisplatin responsiveness in cervical cancer.
    Neoplasia. 2026;81:101372.
    PubMed         Abstract available
    
    

    
    Nurs Open

73. LI D, Wen M, Zhao Y, Nie T, et al
    Prevalence and Factors Associated With Financial Toxicity in Cervical Cancer Patients: A Cross-Sectional Study.
    Nurs Open. 2026;13:e70873.
    PubMed         Abstract available
    
    

    
    Oncol Rep

74. GUO H, Li H, Tian S, Zhang Y, et al
    Loperamide enhances the radiosensitivity of cervical cancer cells via ferroptosis induction.
    Oncol Rep. 2026;56:197.
    PubMed         Abstract available
    
    

    
    Pathogens

75. DOGAN O, Killi MC, Bakir MS, Yuksek S, et al
    Diagnosis of Rare Cervical Tumors: IECC Classification, HPV Status, and Subtype-Directed Immunohistochemistry, with Treatment Outcomes from a Tertiary Center.
    Pathogens. 2026;15:907.
    PubMed         Abstract available
    
    

    
    Pharmaceutics

76. ZHAO N, Zhang X, Luo J, Zhang X, et al
    Study on Echinacoside-Copper Metal-Phenolic Networks Hydrogel System Loaded with Diallyl Trisulfide for Local Treatment of Cervical Cancer.
    Pharmaceutics. 2026;18:1126.
    PubMed         Abstract available
    
    
77. CHEN Q, Yang H, Pei M, Sun Y, et al
    A Locally Injectable, pH/ROS-Responsive Hydrogel Platform for Combination Therapy of Cervical Cancer with Anti-Fibrotic and Chemotherapeutic Agents.
    Pharmaceutics. 2026;18:1115.
    PubMed         Abstract available
    
    

    
    PLoS One

78. CHANG L, Kang Y, Zhu M, Liu J, et al
    Efficacy and safety of immune checkpoint inhibitors combined with TKIs for recurrent or metastatic cervical cancer with PIK3CA mutation.
    PLoS One. 2026;21:e0350571.
    PubMed         Abstract available
    
    

    
    Psychooncology

79. JING S, Dai Z, Yang X, Xin Y, et al
    The Effectiveness of a 6-Week Online Mindfulness-Based Intervention on Patients With Cervical Cancer or High-Grade Squamous Intraepithelial Lesion: A Randomized Controlled Trial Using Multimodal Data of Scales and Electroencephalogram.
    Psychooncology. 2026;35:e70610.
    PubMed         Abstract available
    
    

    
    Public Health

80. AMPOFO AG, Mackenzie LJ, Khumalo P, Chittem M, et al
    Senior High School Nurse-led Education (SHiNE) for improving cervical cancer primary prevention among students in Ghana: Pilot cluster non-randomized controlled trial.
    Public Health. 2026;260:106495.
    PubMed         Abstract available
    
    

    
    Public Health Pract (Oxf)

81. SETIYAWATI N, Sulistyowati S, Priyanto H
    Mapping community-based health promotion strategies for cervical cancer screening uptake: A scoping review of intervention components, delivery models and implementation gaps.
    Public Health Pract (Oxf). 2026;12:100857.
    PubMed         Abstract available
    
    

    
    Radiol Phys Technol

82. A-PHAILUN N, Kadman B, Chanlaor S, Takemura A, et al
    Interfractional variability and reproducibility of accumulated dose in cervical cancer radiotherapy associated with bladder volume.
    Radiol Phys Technol. 2026 Oct 1. doi: 10.1007/s12194-026-01138.
    PubMed         Abstract available
    
    

    
    Res Sq

83. PINTO CLDG, Crespo-Albiac L, Hunter TM, Lin P, et al
    Cervical cancer screening among US women with pelvic organ prolapse.
    Res Sq [Preprint]. 2026 Sep 11:rs.3.rs-10537590.
    PubMed         Abstract available
    
    

    
    Virol J

84. HU X, Zhu M, Wang L, Yang K, et al
    HPV epidemiologic study in Bengbu, China, involving 123,808 women, 2014-2023.
    Virol J. 2026;23:227.
    PubMed         Abstract available
    
    

    
    Womens Health (Lond)

85. MARTINEZ O, Cora-Cruz M, Perez S, French A, et al
    The development of juntas contra el virus del papiloma humano: An HPV self-sampling intervention for underscreened Latinas.
    Womens Health (Lond). 2026;22:17455057261493721.
    PubMed         Abstract available
    
    

    
    World J Radiol

86. WANG SP, Chen ZG, Shan XJ, Jin M, et al
    Development and validation of a multimodal MRI habitat-based deep learning fusion model for predicting (252)Cf neutron therapy response in cervical cancer.
    World J Radiol. 2026;18:123597.
    PubMed         Abstract available
    
    

    
    Zhonghua Fu Chan Ke Za Zhi

87. CHEN R, Yuan Y, Zhang Z, Yang N, et al
    [Inhibition of RBM5 expression by the interaction between hsa_circ_0006200 and EIF4A3 and its impact on cervical cancer progression].
    Zhonghua Fu Chan Ke Za Zhi. 2026;61:748-759.
    PubMed         Abstract available
    
    
88. LING Y, Wu MX, You ZX
    [Clinical observational study on detection and treatment of adenocarcinoma in situ of the cervix].
    Zhonghua Fu Chan Ke Za Zhi. 2026;61:739-747.
    PubMed         Abstract available
    
    
89. WANG Q, Xiao Y, Chao JZ, Ma ZL, et al
    [Analysis of risk factors for pathological upgrading after cervical conization in patients with CIN1].
    Zhonghua Fu Chan Ke Za Zhi. 2026;61:733-738.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum